Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 2 crawled time : 13:03 save search
Pharvaris Doses First Patient in RAPIDe-1, a Phase 2 Study Evaluating PHVS416 for the On-Demand Treatment of HAE
Published: 2021-02-26 (Crawled : 13:03) - globenewswire.com
PHVS | $20.15 -7.99% -7.99% 170K
|
|
| O: -2.92%
H: 3.8%
C: -2.44%
treatment phase 2
Spero Therapeutics Provides Update on SPR720 Phase 2a Clinical Trial
Published: 2021-02-05 (Crawled : 13:03) - globenewswire.com
SPRO | $1.53 -6.71% -6.49% 260K
|
Health Technology
|
| O: -17.02%
H: 32.91%
C: 26.39%
phase 2 trial phase 2b therapeutics
Initial Data from Ongoing Phase 1 Trial of VIR-3434 for Chronic Hepatitis B Virus Infection Demonstrates Significant and Rapid Reduction in Hepatitis B Surface Antigen
Published: 2021-01-26 (Crawled : 13:03) - globenewswire.com
VIR | $8.57 -4.46% -4.91% 770K
|
Health Technology
|
| O: 1.37%
H: 73.96%
C: 71.96%
hepatitis trial phase 3 phase 1 phase 2 injection ongoing infections chronic hepatitis b
Adverum Biotechnologies Completes Patient Enrollment for INFINITY Phase 2 Trial of ADVM-022 in DME and Provides 2021 Business Outlook
Published: 2021-01-11 (Crawled : 13:03) - globenewswire.com
ADVM | $11.53 -1.7% -1.56% 99K
|
Health Technology
|
| O: -0.84%
H: 3.64%
C: 3.31%
biotech trial phase 2 enroll
Vir Biotechnology Announces Initiation of Phase 1 Clinical Trial to Evaluate a Novel Vaccine Platform
Published: 2021-01-06 (Crawled : 13:03) - globenewswire.com
VIR | $8.57 -4.46% -4.91% 770K
|
Health Technology
|
| O: -0.57%
H: 4.54%
C: 1.26%
biotech vaccine trial phase 3 phase 1 phase 2 platform
Ayala Pharmaceuticals to Accelerate Development of AL102 for the Treatment of Desmoid Tumors in Pivotal Phase 2/3 Study
Published: 2021-01-04 (Crawled : 13:03) - globenewswire.com
AYLA | $0.5036 5.84% -0.7% 0
|
Health Technology
|
| O: 7.21%
H: 1.76%
C: -4.52%
treatment phase 2 phase 2/3
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia
Published: 2020-12-31 (Crawled : 13:03) - globenewswire.com
LXRX | $1.87 -5.08% -5.07% 3.5M
|
Health Technology
|
| O: -0.3%
H: 9.63%
C: 3.64%
phase 2
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B
Published: 2020-12-30 (Crawled : 13:03) - globenewswire.com
ALT | $7.55 -5.51% -5.69% 3.2M
|
Commercial Services
|
| O: 3.38%
H: 4.47%
C: -0.63%
trial treatment phase 2 hepatitis chronic hepatitis b
Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors
Published: 2020-12-21 (Crawled : 13:03) - globenewswire.com
MBIO | $0.375 -26.18% -36.34% 700K
|
Health Technology
|
| O: 0.97%
H: 5.47%
C: 4.5%
trial phase 3 phase 1 phase 2 t-cell car-t train
Gainers vs Losers
| 45% | 55% |
Top 10 Gainers
KAVL | $6.3 135.96% 57.45% 44M
|
Wholesale Trade
PXMD | $0.74 79.7% 44.16% 4.5M
|
Health Technology
DYNT | $0.3704 -5.27% 43.09% 5.5M
|
Health Technology
LGVN P 3 d | $2.93 73.37% 42.52% 56M
|
HUBC | $1.95 50.0% 32.99% 73M
|
n/a
SPCB | $0.4004 45.07% 31.75% 130M
|
Electronic Technology
ONVO | $1.35 33.65% 24.62% 53M
|
Health Technology
OMQS | $0.7038 35.35% 24.3% 3.5M
|
Professional, Scientific, and T...
SNPO | $10.54 29.48% 22.88% 3.9M
|
EEIQ | $1.16 27.46% 20.86% 6.9K
|
Educational Services
Your saved searches
Save your searches and get alerts when important news are released.